Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia

NCT00552500 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00552500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00552500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2003
Completion date
December 31, 2005
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body composition, insulin resistance